ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

October 24, 1975

NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis

July 4, 1975

Senate committee approves $1.1 billion increase for NIH.

October 1, 2004

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990